APA (7th ed.) Citation

Te-Ling Lu, Wei-Ting Chang, Chee-Hong Chan, Sheng-Nan Wu, & Sheng-Nan Wu. (2019). Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Te-Ling Lu, Wei-Ting Chang, Chee-Hong Chan, Sheng-Nan Wu, and Sheng-Nan Wu. Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Te-Ling Lu, et al. Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Frontiers Media S.A., 2019.